These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2534415)

  • 21. Prevention of stroke and brain damage with calcium antagonists in animals.
    Sauter A; Rudin M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):121S-127S. PubMed ID: 1827001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of isradipine in hypertension following coronary artery bypass surgery.
    Underwood SM; Feneck RO; Davies SW; Walesby RK; Lunnon MW
    Am J Med; 1989 Apr; 86(4A):81-7. PubMed ID: 2523661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.
    McGrath BP; Newman R; Older P
    Am J Med; 1989 Apr; 86(4A):75-80. PubMed ID: 2523660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive and hemodynamic effects of calcium channel blockade with isradipine after acute exercise.
    Cléroux J; Yardley C; Marshall A; Coulombe D; Lacourcière Y
    Am J Hypertens; 1992 Feb; 5(2):84-7. PubMed ID: 1532316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment.
    Safar ME; Toto-Moukouo JJ; Bouthier JA; Asmar RE; Levenson JA; Simon AC; London GM
    Circulation; 1987 Jan; 75(1 Pt 2):I156-61. PubMed ID: 2947747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.
    Sugishita Y; Iida K; Yukisada K; Ito I
    J Am Coll Cardiol; 1990 Mar; 15(3):665-71. PubMed ID: 2137479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isradipine (Lomir) in the treatment of hypertension. Introduction.
    Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):1. PubMed ID: 2143456
    [No Abstract]   [Full Text] [Related]  

  • 29. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 30. Protective effects of antihypertensive treatment with isradipine on the consequences of cerebral ischaemia in the spontaneously hypertensive rat.
    Bentahila S; Atkinson J; Capdeville C
    J Hypertens; 1991 Feb; 9(2):121-9. PubMed ID: 1849526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
    Jespersen LT; Krusell LR; Sihm I; Pedersen OL
    Am J Med; 1989 Apr; 86(4A):57-9. PubMed ID: 2523656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From channels to cats: an overview of isradipine pharmacology.
    Rüegg UT; Hof RP
    Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
    [No Abstract]   [Full Text] [Related]  

  • 33. Isradipine in hypertension. Proceedings of an international symposium. Athens, Greece, October 21, 1988.
    Am J Med; 1989 Apr; 86(4A):1-146. PubMed ID: 2523643
    [No Abstract]   [Full Text] [Related]  

  • 34. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].
    Bakhshaliev AB; Akhmetzianova EKh; Gadzhiev RF; Teboeva RV
    Klin Med (Mosk); 1989 Mar; 67(3):10-7. PubMed ID: 2526273
    [No Abstract]   [Full Text] [Related]  

  • 36. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of left ventricular hypertrophy in hypertensive patients: responses to exercise by antihypertensive treatment.
    Arita M; Fujiwara S; Ueno Y; Shiotani M; Nakamura Y; Nakatsu C; Nishio I; Masuyama Y
    Jpn Circ J; 1990 May; 54(5):575-80. PubMed ID: 1977937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.